基于Cyclomatrix多酸的交联多种药物纳米颗粒作为无载体HCPT和DOX联合输送系统,用于瘤组合化疗
1State Key Laboratory of Natural Product Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.
Colloids and surfaces. B, Biointerfaces
|March 11, 2026
概括
新型循环矩阵聚酶纳米药物同时提供HCPT和DOX,用于增强瘤化疗. 这种pH触发系统显示出显著的协同效应和受控的药物释放.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 循环聚酶纳米药在瘤化疗中具有优势,原因是易于合成,pH触发的降解和生物安全性.
- 六环三酸 (HCCP) 能够对受控释放和双重药物输送进行结构调节.
研究的目的:
- 开发和优化使用HCPT作为基于HCCP的纳米药物的链接器的双药联合递送系统.
- 通过 HCPT 和 DOX 的受控,pH 触发的释放来实现增强瘤化疗.
主要方法:
- 合成了HCPT-HCCP-DOX纳米颗粒,通过将10-酸托素 (HCPT) 作为链接剂.
- 评估了纳米粒子药物负载,pH触发的释放动力学和体外协同效应.
主要成果:
- 优化的纳米粒子实现了高药含量:52.4%的HCPT和32.6%的DOX.
- 已证明瘤细胞内微环境触发释放:85.6%的DOX和63.4%的HCPT在84小时内释放,<10%的过早泄漏.
- 证实了强大的协同效应,组合指数 (CI) 为0.054.
结论:
- HCPT-HCCP-DOX纳米药物系统有效地同时提供两种有控制释放的药物.
- 开发的系统表现出显著的协同抗瘤效应,突出其在化疗中的潜力.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79
Modified-Release Drug Delivery Systems: Site-Targeted
70
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70
Modified-Release Drug Delivery Systems: Rate-Programmed II
66
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
66


